| Name | 2-(6-bromo-2,3-dihydro-1,4-benzoxazin-4-yl)-6,6-dimethyl-5,7-dihydro-[1,3]thiazolo[5,4-c]pyridin-4-one |
|---|
| Molecular Formula | C16H16BrN3O2S |
|---|---|
| Molecular Weight | 394.28600 |
| Exact Mass | 393.01500 |
| PSA | 82.70000 |
| LogP | 3.89440 |
| HS Code | 2934999090 |
|---|
|
~78%
1000793-42-9 |
| Literature: AVILA THERAPEUTICS, INC. Patent: US2011/230476 A1, 2011 ; Location in patent: Page/Page column 293 ; |
|
~15%
1000793-42-9 |
| Literature: UCB PHARMA S.A. Patent: WO2009/71888 A1, 2009 ; Location in patent: Page/Page column 73-74 ; WO 2009/071888 A1 |
|
~80%
1000793-42-9 |
| Literature: Petter, Russell C.; Jewell, Charles F.; Lee, Kwangho; Medikonda, Aravind Prasad; Niu, Deqiang; Qiao, Lixin; Singh, Juswinder; Zhu, Zhendong Patent: US2011/269244 A1, 2011 ; Location in patent: Page/Page column ; |
|
~%
1000793-42-9 |
| Literature: AVILA THERAPEUTICS, INC. Patent: US2011/230476 A1, 2011 ; |
|
~%
1000793-42-9 |
| Literature: AVILA THERAPEUTICS, INC. Patent: US2011/230476 A1, 2011 ; |
|
~%
1000793-42-9 |
| Literature: AVILA THERAPEUTICS, INC. Patent: US2011/230476 A1, 2011 ; |
|
~%
1000793-42-9 |
| Literature: AVILA THERAPEUTICS, INC. Patent: US2011/230476 A1, 2011 ; |
|
~%
1000793-42-9 |
| Literature: AVILA THERAPEUTICS, INC. Patent: US2011/230476 A1, 2011 ; |
|
~%
1000793-42-9 |
| Literature: AVILA THERAPEUTICS, INC. Patent: US2011/230476 A1, 2011 ; |
| Precursor 10 | |
|---|---|
| DownStream 1 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |